Persistent Asset Partners’s Merck MRK Stock Holding History

Persistent Asset Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,471	Closed	-$401K	–	426
2025 Q4	$365K	Buy	+3,471	New	+$326K	0.16%	161
2025 Q3	–	Sell	-4,647	Closed	-$368K	–	275
2025 Q2	$368K	Buy	+4,647	New	+$369K	0.27%	92
2025 Q1	–	Sell	-13,422	Closed	-$1.33M	–	198
2024 Q4	$1.33M	Buy	+13,422	New	+$1.38M	1.1%	25

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Persistent Asset Partners's MRK Position: Q1 2026 in Review

Persistent Asset Partners sold out of Merck (MRK) in Q1 2026, closing a stake of 3,471 shares — an estimated $401K sold.

Persistent Asset Partners first reported a position in MRK in Q4 2024 and held it in 3 quarters. The position peaked at $1.33M in Q4 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Persistent Asset Partners reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Persistent Asset Partners sold 3,471 Merck shares in Q1 2026, an estimated $401K.
Persistent Asset Partners first reported a position in Merck in Q4 2024 and held it in 3 quarters.
Persistent Asset Partners's Merck position peaked at $1.33M in Q4 2024.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.